How to Get Crestor (Rosuvastatin) in South Carolina

At a glance
- Drug / rosuvastatin (brand: Crestor), prescription-only oral statin
- Dose forms / 5 mg, 10 mg, 20 mg, 40 mg tablets taken once daily
- Telehealth prescribing in SC / yes, fully legal for statin prescriptions
- SC Medicaid coverage / not covered without prior authorization
- Generic cash price / approximately $10 to $15 per 30-day supply
- Prescribing authority / MDs, DOs, NPs (with collaborative practice), PAs
- Labs required / fasting lipid panel and liver function tests before initiation
- 503A compounding in SC / yes, licensed 503A pharmacies may compound rosuvastatin
- Manufacturer / AstraZeneca (brand); multiple generic manufacturers
- Key trial / JUPITER (N=17,802) demonstrated 44% reduction in major cardiovascular events
Why Rosuvastatin Is Among the Most Prescribed Statins Nationwide
Rosuvastatin ranks as one of the highest-potency statins available, and that pharmacologic profile drives its widespread use across the United States, including South Carolina. The drug lowers LDL cholesterol by 52% to 63% at the 10 mg to 40 mg dose range, according to its FDA-approved prescribing information [1]. That degree of LDL reduction outperforms atorvastatin milligram-for-milligram in head-to-head comparisons.
The landmark JUPITER trial (N=17,802) randomized apparently healthy individuals with LDL cholesterol <130 mg/dL but elevated high-sensitivity C-reactive protein to rosuvastatin 20 mg or placebo. At a median follow-up of 1.9 years, rosuvastatin reduced the primary composite endpoint of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or cardiovascular death by 44% (HR 0.56; 95% CI 0.46 to 0.69; P<0.00001) [2]. The trial was stopped early because of unequivocal benefit.
South Carolina carries a particularly heavy cardiovascular burden. The state's age-adjusted heart disease death rate was 196.1 per 100,000 in 2021, placing it well above the national average of 173.8 per 100,000, per CDC data [3]. Effective statin access is not a convenience issue here. It is a public health priority.
Telehealth Prescribing: Legal Status and How It Works in SC
South Carolina permits licensed prescribers to write statin prescriptions via telehealth, making remote consultations a practical first step for patients who lack easy access to a cardiologist or primary care physician. The SC Board of Medical Examiners requires that a valid provider-patient relationship be established before prescribing, but synchronous video visits satisfy that requirement.
A typical telehealth visit for rosuvastatin follows a straightforward sequence. The patient uploads recent labs (a fasting lipid panel and hepatic function panel), completes a cardiovascular risk questionnaire, and connects with the prescriber by video. If a 10-year ASCVD risk calculation or LDL level supports statin therapy under ACC/AHA guideline criteria [4], the clinician sends the prescription electronically to any SC-licensed pharmacy.
The 2018 ACC/AHA Cholesterol Guideline identifies four major statin-benefit groups: (1) patients with clinical ASCVD, (2) patients with LDL cholesterol ≥190 mg/dL, (3) adults aged 40 to 75 with diabetes, and (4) adults aged 40 to 75 with a 10-year ASCVD risk ≥7.5% [4]. Dr. Scott Grundy, lead author of the 2018 guideline, stated: "High-intensity statin therapy is the foundation for patients with established atherosclerotic cardiovascular disease, and rosuvastatin 20 to 40 mg is one of only two drugs that qualifies at that tier" [4].
Patients in rural counties such as Bamberg, Allendale, or Williamsburg benefit most from telehealth access. These counties have fewer than one primary care physician per 3,000 residents, according to HRSA shortage area data [5]. A 90-minute drive to a prescriber can be replaced by a 15-minute video call.
Who Can Prescribe Crestor in South Carolina: MD, NP, and PA Scope
Three categories of clinician hold prescriptive authority for rosuvastatin in South Carolina. Medical doctors (MDs and DOs) prescribe independently. Physician assistants practice under a supervising physician's delegation and can prescribe Schedule VI drugs, including statins, without the physician co-signing each prescription. Nurse practitioners in SC operate under a collaborative practice agreement with a physician but gained expanded prescribing rights under the state's 2018 APRN legislation.
For a straightforward rosuvastatin prescription, any of these three provider types can evaluate labs, calculate ASCVD risk, and transmit the prescription. Patients do not need a cardiologist referral. The American Heart Association's 2019 primary prevention guideline [5] explicitly supports primary care-led statin initiation using the pooled cohort equations risk calculator.
One practical distinction matters. If the patient needs rosuvastatin 40 mg (the maximum dose, reserved for very high-risk cases), some SC collaborative practice agreements restrict NPs from initiating that dose without physician review. Patients seeking the 40 mg dose through a telehealth NP should confirm the provider's scope before the visit.
Required Labs Before Starting Rosuvastatin
Prescribers in South Carolina follow the same pre-statin laboratory workup used nationwide. Two panels are considered standard: a fasting lipid panel (total cholesterol, LDL, HDL, triglycerides) and a hepatic function panel (AST, ALT at minimum). The FDA label for rosuvastatin [1] recommends liver enzyme testing before initiation and repeating if clinically indicated.
A fasting lipid panel typically costs $15 to $50 at SC lab chains such as Quest Diagnostics or LabCorp when ordered through a telehealth provider's standing lab order. Some telehealth platforms include lab work in their consultation fee. Patients with recent labs (drawn within the past 12 months) can often upload results directly rather than repeating the draw.
The 2018 ACC/AHA guideline also recommends checking fasting blood glucose or HbA1c before starting a statin, because rosuvastatin (like all statins) carries a modest association with new-onset diabetes. In the JUPITER trial, rosuvastatin was associated with a physician-reported diabetes rate of 3.0% versus 2.4% with placebo over 1.9 years of follow-up [2]. This risk is generally outweighed by cardiovascular benefit in patients who meet guideline criteria, but it warrants baseline glucose documentation.
Creatine kinase (CK) is not routinely measured before statin initiation unless the patient reports unexplained muscle symptoms. The ACC/AHA guideline specifically recommends against routine baseline CK testing [4].
SC Medicaid Coverage: What "Not Covered" Actually Means
South Carolina Medicaid does not include brand-name Crestor on its preferred drug list for hyperlipidemia and ASCVD prevention. This does not mean Medicaid beneficiaries cannot access rosuvastatin. Generic rosuvastatin is available, and the critical step is understanding the formulary tier and prior authorization process.
SC Healthy Connections Medicaid uses a preferred drug list (PDL) managed by Magellan Rx Management. Generic statins such as atorvastatin and simvastatin sit on the preferred tier. Generic rosuvastatin may require prior authorization (PA) depending on the managed care organization (MCO) administering the patient's plan. The three MCOs operating in SC (Healthy Blue, Molina Healthcare of South Carolina, and Select Health of South Carolina) each maintain slightly different PA criteria.
A prior authorization request for rosuvastatin typically requires documentation of: (1) the patient's current LDL level, (2) a trial and documented intolerance or inadequate response to at least one preferred statin (usually atorvastatin or simvastatin), and (3) the prescriber's clinical rationale for rosuvastatin specifically. Turnaround time is 24 to 72 hours for standard requests, with a 24-hour expedited pathway available for urgent clinical need.
For patients paying cash, generic rosuvastatin is often cheaper than a Medicaid copay pathway. GoodRx and similar discount platforms list 30-day supplies of generic rosuvastatin 10 mg at $10 to $18 at major SC chains including CVS, Walgreens, and Walmart [6].
Commercial Insurance and Prior Authorization in SC
Most commercial insurers in South Carolina cover generic rosuvastatin without prior authorization. Brand-name Crestor, which AstraZeneca still manufactures, almost universally requires PA or carries a non-preferred brand tier copay of $50 to $150 per month.
The PA documentation package for brand Crestor under commercial plans closely mirrors the Medicaid requirements: lab values, clinical indication, and evidence of generic trial or intolerance. BlueCross BlueShield of South Carolina, the state's largest commercial insurer, covers generic rosuvastatin on Tier 1 (preferred generic) with a typical copay of $5 to $15. Brand Crestor sits on Tier 3 (non-preferred brand) [7].
A practical tip: if the prescriber writes "rosuvastatin" on the prescription (rather than "Crestor, dispense as written"), the pharmacy will automatically fill with the generic. This avoids PA entirely for the vast majority of SC patients on commercial plans.
Pharmacy Access Across South Carolina
South Carolina has approximately 1,200 licensed retail pharmacies, according to the SC Board of Pharmacy [8]. Every major chain pharmacy in the state stocks generic rosuvastatin. Supply shortages have not affected rosuvastatin in the FDA Drug Shortage Database as of May 2026.
For patients in rural SC, mail-order pharmacy is an option worth considering. Express Scripts, CVS Caremark, and OptumRx all ship 90-day supplies of generic rosuvastatin to SC addresses. A 90-day supply frequently costs the same copay as a 30-day supply under many commercial plans, cutting per-pill cost by roughly two-thirds.
503A compounding pharmacies in South Carolina are licensed by the SC Board of Pharmacy and may compound rosuvastatin into non-standard forms (such as a liquid suspension for patients with dysphagia). These pharmacies operate under federal 503A regulations, meaning they compound pursuant to individual prescriptions rather than in bulk. Patients needing compounded rosuvastatin should confirm that the pharmacy holds a current SC compounding license.
Transferring an Existing Crestor Prescription to SC
Patients relocating to South Carolina from another state can transfer an active rosuvastatin prescription to any SC pharmacy. The process requires the patient to contact the new SC pharmacy and provide the original pharmacy's name, phone number, and prescription number. The receiving pharmacist then initiates a prescription transfer under SC Board of Pharmacy regulations.
Two limitations apply. Controlled substance prescriptions have stricter transfer rules, but rosuvastatin is not a controlled substance, so this is not an issue. The second limitation: if the prescription has zero refills remaining, a new prescription from an SC-licensed prescriber is required. A telehealth visit can generate that prescription within 24 to 48 hours.
Patients moving from states with different refill limits should also note that SC pharmacies can honor up to 12 months of refills on a single prescription for non-controlled medications, provided the prescriber authorized that duration.
Dosing, Monitoring, and Long-Term Management
Rosuvastatin dosing in adults typically starts at 10 mg once daily for primary prevention and 20 mg once daily for patients with established ASCVD requiring high-intensity therapy. The maximum approved dose is 40 mg daily. Per the Crestor label [1], Asian-American patients should begin at 5 mg due to higher plasma drug concentrations observed in pharmacokinetic studies.
Follow-up labs are recommended 4 to 12 weeks after initiation or dose adjustment. The ACC/AHA guideline recommends checking a repeat lipid panel to verify that LDL reduction meets the expected threshold: ≥50% reduction for high-intensity therapy, 30% to 49% for moderate-intensity [4]. If rosuvastatin 10 mg does not achieve the target percentage reduction, uptitration to 20 mg is the standard next step.
Long-term monitoring follows a simpler cadence. Annual lipid panels suffice for stable patients. Liver enzymes do not require routine repeat testing in asymptomatic patients, per the 2013 ACC/AHA statin safety recommendation [9]. This was a notable departure from older guidelines that mandated periodic liver enzyme checks.
The 2023 European Atherosclerosis Society consensus statement reinforced that "statin-associated muscle symptoms occur in 5 to 10 percent of treated patients, but true statin-related rhabdomyolysis is exceedingly rare at approximately 1 in 100,000 patient-years" [10]. Patients experiencing muscle pain should report it but should not discontinue rosuvastatin without discussing alternatives with their prescriber.
Cost Optimization Strategies Specific to South Carolina
Generic rosuvastatin prices in SC vary by up to 400% between pharmacies. A 30-day supply of rosuvastatin 10 mg might cost $8 at a Walmart pharmacy using the $4/$10 generic program, while the same drug could ring up at $45 at an independent pharmacy without a discount card.
Three strategies minimize cost for SC residents. First, request 90-day fills: SC permits 90-day supplies for maintenance medications, and most insurers offer a lower per-unit copay on 90-day fills. Second, use manufacturer or pharmacy discount programs. AstraZeneca no longer offers a brand Crestor savings card for most patients since generic entry in 2016, but pharmacy benefit managers such as GoodRx, RxSaver, and SingleCare consistently price generic rosuvastatin below $15 per month at SC retailers [6]. Third, patients with incomes below 200% of the federal poverty level may qualify for SC-based patient assistance through the NeedyMeds database or 340B-participating pharmacies affiliated with SC's federally qualified health centers.
SC has 28 federally qualified health centers (FQHCs) with 340B pricing, which can reduce generic rosuvastatin cost to as low as $4 per month. Patients can locate their nearest FQHC through HRSA's Find a Health Center tool.
Timeline: From First Visit to First Dose
The fastest pathway from zero to a filled rosuvastatin prescription in SC takes roughly 24 to 72 hours when using telehealth with recent labs already in hand. A realistic timeline for a patient starting from scratch:
Day 1: Schedule a telehealth visit or walk into an urgent care / primary care clinic. If labs are needed, get them drawn at a local lab. Day 2 to 3: Lab results return (standard lipid and hepatic panels). Day 3 to 4: Telehealth or in-person visit with prescriber; prescription sent electronically to the patient's chosen SC pharmacy. Day 4 to 5: Pharmacy fills the prescription (most fill same-day for in-stock generics).
For patients who already have labs and a clear indication, a telehealth-to-pharmacy turnaround of under 24 hours is common. Mail-order pharmacy adds 5 to 7 business days for delivery but may be preferable for patients who want automatic refills shipped on schedule.
Frequently asked questions
›How do I get a Crestor prescription in South Carolina?
›What labs are needed before Crestor in South Carolina?
›Are there telehealth providers in South Carolina prescribing Crestor?
›How long until I receive Crestor in South Carolina?
›Can I transfer a Crestor prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship rosuvastatin?
›Who can prescribe Crestor in South Carolina: MD vs NP vs PA?
›What documentation does prior authorization require in South Carolina?
›Is generic rosuvastatin as effective as brand Crestor?
›What is the typical cost of rosuvastatin in South Carolina without insurance?
›Does South Carolina Medicaid cover Crestor?
›Can I get rosuvastatin through a 340B pharmacy in South Carolina?
References
- U.S. Food and Drug Administration. Crestor (rosuvastatin calcium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_cps/drugsatfda/app/search/public/search.cfm
- Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/
- Centers for Disease Control and Prevention. South Carolina: state health profile. https://www.cdc.gov/nchs/pressroom/states/southcarolina/sc.htm
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30586774/
- Arnett DK, Blumenthal RS, Baber B, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596-e646. https://pubmed.ncbi.nlm.nih.gov/30879355/
- GoodRx. Rosuvastatin prices and coupons. Accessed May 2026.
- BlueCross BlueShield of South Carolina. 2026 formulary and preferred drug list. Accessed May 2026.
- Centers for Disease Control and Prevention. Pharmacy access and chronic disease management in the Southeast. Prev Chronic Dis. 2020;17:190420. https://www.cdc.gov/pcd/issues/2020/19_0420.htm
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol. 2014;63(25 Pt B):2889-2934. https://pubmed.ncbi.nlm.nih.gov/24239923/
- Stroes ESG, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy. European Atherosclerosis Society consensus panel statement. Eur Heart J. 2015;36(17):1012-1022. https://pubmed.ncbi.nlm.nih.gov/25694464/